Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: hospital water supply and human faeces
DNA G+C(%): 66.7-67.9
|
Lower T(℃): 25(+)
Mid T(℃): 37(+)
High T(℃): 42(neg)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
amoxicillin: R64)
Augmentin: S(2)
penicillin: R(64-128)
piperacillin: Var(MIC50): 8-16), MIC90: Var(8-16
ticarcillin: S(<0.25)
imipenem: SensRNG: (0.5-1)
|
cefepime: S(1)
cefoxitin: S(2)
ceftazidime: Var(MIC50): 8-16), MIC90: Var(8-16
cephalothin: S(1)
|
amikacin: SensRNG: (0.5-2)
gentamicin: S(4)
netilmycin: Var(MIC50): 8-16), MIC90: Var(8-16
tobramycin: S(2)
|
erythromycin: SensRNG: (0.5-1)
|
ciprofloxacin: Var(MIC50): 2-8), MIC90: Var(2-8
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(<0.25)
|
vancomycin: R(4-128)
|
rifampicin: S(0.5)
|
trimethoprim: R(256)
|
colistin: Var(MIC50): 4-128), MIC90: Var(4-128
|